New combo therapy offers hope for relapsed lymphoma patients
Disease control
Recruiting now
This study tests a combination of two drugs—pembrolizumab and all-trans retinoic acid—in adults with relapsed or refractory Hodgkin lymphoma or B-Non-Hodgkin lymphoma. The goal is to see if the combo is safe and can shrink tumors. About 24 participants will receive the treatment …
Phase: PHASE2 • Sponsor: Rita Assi • Aim: Disease control
Last updated May 14, 2026 12:05 UTC